Skip to content

The effect of COVID-19 stigmatization on adherence to governmental behavioral recommendations and psychological distress

The effect of COVID-19 stigmatization on adherence to governmental behavioral recommendations and psychological distress - COVID-19 stigma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00029552
Enrollment
400
Registered
2022-07-05
Start date
2021-03-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 depressive symptomatology

Interventions

Group 1: People at high risk of infection for COVID-19 take part in a one-time survey where they are asked to complete a questionnaire on stigmatization, following governmental behavioral recommendati

Sponsors

Universität Leipzig, Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - current/past exposition to high risk of being infected with SARS-CoV-2 by either a) having had contact with a person tested positively for COVID-19, b) having suffered from symptoms that might be due to COVID-19, c) entering Germany after returning from traveling in a high-risk area for COVID-19 - exposition took place after 11/2020 - age = 18 years, - place of residence in Germany - fluent in speaking German

Exclusion criteria

Exclusion criteria: No informed consent

Design outcomes

Primary

MeasureTime frame
Cross-sectional study. Stigmatization items were adapted from validated stigma scales for HIV and chronic illness (Dinkel et al., 2014; Earnshaw et al., 2013; Earnshaw et al., 2020; Visser et al., 2008). Items assessing adherence to governmental behavioral recommendations were created based upon the official behavioral recommendations of the Federal Centre for Health Education.

Secondary

MeasureTime frame
Psychological distress (depressive symptoms, anxiety symptoms) was measured with the PHQ-4 (Kroenke et al., 2009; Löwe et al., 2010).

Countries

Germany

Contacts

Public ContactAnette Kersting

Universität Leipzig, Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie

Anette.Kersting@medizin.uni-leipzig.de0049 341 9718850

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026